Claire Lethias

Prof. Claire Lethias


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JEJean-Yves Exposito
Jean-Yves Exposito
UVUlrich Valcourt
Ulrich Valcourt
CCCaroline Cluzel
Caroline Cluzel
CLClaire Lethias
Claire Lethias
Collagens, or more precisely collagen-based extracellular matrices, are often considered as a metazoan hallmark. Among the collagens, fibrillar collagens are present from sponges to humans, and are involved in the formation of the well-known striated fibrils. In this review we discuss the different steps in the evolution of this protein family, from the formation of an ancestral fibrillar collagen gene to the formation of different clades. Genomic data from the choanoflagellate (sister group of Metazoa) Monosiga brevicollis, and from diploblast animals, have suggested that the formation of an ancestral α chain occurred before the metazoan radiation. Phylogenetic studies have suggested an early emergence of the three clades that were first described in mammals. Hence the duplication events leading to the formation of the A, B and C clades occurred before the eumetazoan radiation. Another important event has been the two rounds of “whole genome duplication” leading to the amplification of fibrillar collagen gene numbers, and the importance of this diversification in developmental processes. We will also discuss some other aspects of fibrillar collagen evolution such as the development of the molecular mechanisms involved in the formation of procollagen molecules and of striated fibrils.

26 October 2006 in FEBS Letters
Verified
Journal Article
Closed access
CLClaire Lethias
Claire Lethias
ACAlexandre Carisey
Alexandre Carisey
JCJane Comte
Jane Comte
CCCaroline Cluzel
Caroline Cluzel
JEJean-Yves Exposito
Jean-Yves Exposito

1 August 1999 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
FEFlorent Elefteriou
Florent Elefteriou
JEJean‐Yves Exposito
Jean‐Yves Exposito
RGRobert Garrone
Robert Garrone
CLClaire Lethias
Claire Lethias
Adhesive properties of tenascin‐X (TN‐X) were investigated using TN‐X purified from bovine skin and recombinant proteins encompassing the RGD sequence located within the tenth fibronectin type‐III domain, and the fibrinogen‐like domain. Osteosarcoma (MG63) and bladder carcinoma cells (ECV304) cells were shown to adhere to purified TN‐X, but did not spread and did not assemble actin stress fibers. Both cell types adhered to recombinant proteins harboring the contiguous fibronectin type‐III domains 9 and 10 (FNX 9‐10) but not to the FNX 10 domain alone. This adhesion to FNX 9‐10 was shown to be mediated by αvβ3 integrin, was inhibited by RGD peptides and was strongly reduced in proteins mutated within the RGD site. As antibodies against αvβ3 integrin had no effects on cell adhesion to purified TN‐X, we suggest that the RGD sequence is masked in intact TN‐X. Cell attachment to the recombinant TN‐X fibrinogen domain (FbgX) and to purified TN‐X was greater for MG63 than for ECV304 cells. A β1‐containing integrin was shown to be involved in MG63 cell attachment to FbgX and to purified TN‐X. Although the existence of other cell interaction sites is likely in this huge molecule, these similar patterns of adhesion and inhibition suggest that the fibrinogen domain might be a dominant site in the whole molecule.

1 May 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
CLClaire Lethias
Claire Lethias
FEFlorent Elefteriou
Florent Elefteriou
GPGoetz Parsiegla
Goetz Parsiegla
JEJean-Yves Exposito
Jean-Yves Exposito
RGRobert Garrone
Robert Garrone
Tenascin-X is known as a heparin-binding molecule, but the localization of the heparin-binding site has not been investigated until now. We show here that, unlike tenascin-C, the recombinant fibrinogen-like domain of tenascin-X is not involved in heparin binding. On the other hand, the two contiguous fibronectin type III repeats b10 and b11 have a predicted positive charge at physiological pH, hence a set of recombinant proteins comprising these domains was tested for interaction with heparin. Using solid phase assays and affinity chromatography, we found that interaction with heparin was conformational and involved both domains 10 and 11. Construction of a three-dimensional model of domains 10 and 11 led us to predict exposed residues that were then submitted to site-directed mutagenesis. In this way, we identified the basic residues within each domain that are crucial for this interaction. Blocking experiments using antibodies against domain 10 were performed to test the efficiency of this site within intact tenascin-X. Binding was significantly reduced, arguing for the activity of a heparin-binding site involving domains 10 and 11 in the whole molecule. Finally, the biological significance of this site was tested by cell adhesion studies. Heparan sulfate cell surface receptors are able to interact with proteins bearing domains 10 and 11, suggesting that tenascin-X may activate different signals to regulate cell behavior.